Rufus Baretti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rufus Baretti has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
R. Hetzer
14 shared publicationsC. Knosalla
Deutsches Herzzentrum Berlin, Berlin, Germany
6 shared publicationsB. Debus
Deutsches Herzzentrum Berlin, Berlin, Germany
5 shared publicationsAsatoshi Mizuno
Division of Cardiothoracic Surgery, UCLA School of Medicine, Los Angeles, CA , USA
4 shared publicationsB.-S. Lin
Deutsches Herzzentrum Berlin, Berlin, Germany
4 shared publicationsGerald D. Buckberg
Division of Cardiothoracic Surgery, UCLA School of Medicine, Los Angeles, CA , USA
4 shared publications
Latest Publications
- 2 November 2015
- Published by Springer Nature in Heilberufe
- Vol. 67 (11) , 24-27
Bypass, Stent oder Pillen?
- 2 November 2015
- Published by Springer Nature in Heilberufe
- Vol. 67 (11) , 24-27
Bypass, Stent oder Pillen?
- 20 January 2015
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 63 (S 01) , OP53
Sinus Rhythm Recovers after Coronary Artery Bypass Grafting (CABG) Combined with Maze Procedure and Parallels the Rate of Recovery after Sole CABG
Objectives: Atrial fibrillation (AF) can be successfully converted into sinus rhythm (SR) with the modified maze procedure, i.e., epicardial pulmonary vein isolation and transmural thermocoagulation. The rate of recovery from AF to SR in patients suffering from coronary artery disease (CAD) and AF is under discussion for the combined CABG-MAZE procedure. CABG itself can cause arrhythmia postoperatively. We investigated the rate of recovery to SR after combined CABG-MAZE and CABG alone. Methods: Cohorts of patients suffering from CAD in isolation or in combination with AF were consecutively operated on in 2011 with sole CABG or combined CABG-MAZE procedure (n = 86 each). Demographic and clinical data (mean±SD) for CABG-MAZE vs Sole-CABG patients were: age 71 ± 8 vs 68 ± 8 years, female 22 vs 20%, body height 174 ± 9 vs 172 ± 8 cm, body weight* 86 ± 18 vs 79 ± 13 kg, BMI>25* 80 vs 68%, LVEF 46 ± 12 vs 50 ± 11%, NYHA* 1.3 ± 1.4 vs 0.6 ± 1.0, CAD-1 2 vs 1%, CAD-2* 21 vs 9%, CAD-3* 77 vs 90%, renal failure* 29 vs 15%, COPD* 19 vs 13%. Preoperatively, AF was paroxysmal in 47 (54%) patients, persistent in 18 (21%) patients and chronic in 21 patients (25%) in the CABG-MAZE group. All patients of the Sole-CABG group had SR without AF. Postoperative follow up was observed for 1 year. Results: The duration (min) of the operation was similar for both groups (CABG-MAZE vs Sole-CABG): 256 ± 74 vs 249 ± 51, aortic cross-clamping 54 ± 20 vs 57 ± 17, reperfusion 39 ± 21 vs 39 ± 14. The number of bypass grafts was also similar with use of the LIMA [GA1] (CABG-MAZE vs Sole-CABG) 0.9 ± 0.4 vs 0.9 ± 0.3 and did not differ significantly with use of venous grafts 1.9 ± 0.8 vs 1.2 ± 0.7. SR occurred (%) in the CABG-MAZE vs Sole-CABG group intraoperatively in 74 vs 98, decreased in parallel on postoperative day (POD) 1 and 3 to 54 vs 69 and 35 vs 58, and escalated again in parallel until 6 months and 1 year postoperatively to 51 vs 91 and 55 vs 87. AF-subgroups (paroxysmal, persistent, chronic) had converted to SR 1 year postoperatively in 70, 45 and 27%, respectively. Cumulative survival (%) for CABG-MAZE vs Sole-CABG was at POD 30 99 in both, at 6 months* 92 vs 99, and 1 year* 86 vs 98. Conclusions: Over half the patients with the combined CABG-MAZE operation had developed SR after 1 year. The reinstatement of SR in patients suffering from CAD and AF paralleled the rate of SR recovery in patients with preoperative SR and sole CABG procedure, 87% of whom showed SR 1 year after sole CABG. * significance p < 0.05
- 20 January 2015
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 63 (S 01) , OP53
Sinus Rhythm Recovers after Coronary Artery Bypass Grafting (CABG) Combined with Maze Procedure and Parallels the Rate of Recovery after Sole CABG
Objectives: Atrial fibrillation (AF) can be successfully converted into sinus rhythm (SR) with the modified maze procedure, i.e., epicardial pulmonary vein isolation and transmural thermocoagulation. The rate of recovery from AF to SR in patients suffering from coronary artery disease (CAD) and AF is under discussion for the combined CABG-MAZE procedure. CABG itself can cause arrhythmia postoperatively. We investigated the rate of recovery to SR after combined CABG-MAZE and CABG alone. Methods: Cohorts of patients suffering from CAD in isolation or in combination with AF were consecutively operated on in 2011 with sole CABG or combined CABG-MAZE procedure (n = 86 each). Demographic and clinical data (mean±SD) for CABG-MAZE vs Sole-CABG patients were: age 71 ± 8 vs 68 ± 8 years, female 22 vs 20%, body height 174 ± 9 vs 172 ± 8 cm, body weight* 86 ± 18 vs 79 ± 13 kg, BMI>25* 80 vs 68%, LVEF 46 ± 12 vs 50 ± 11%, NYHA* 1.3 ± 1.4 vs 0.6 ± 1.0, CAD-1 2 vs 1%, CAD-2* 21 vs 9%, CAD-3* 77 vs 90%, renal failure* 29 vs 15%, COPD* 19 vs 13%. Preoperatively, AF was paroxysmal in 47 (54%) patients, persistent in 18 (21%) patients and chronic in 21 patients (25%) in the CABG-MAZE group. All patients of the Sole-CABG group had SR without AF. Postoperative follow up was observed for 1 year. Results: The duration (min) of the operation was similar for both groups (CABG-MAZE vs Sole-CABG): 256 ± 74 vs 249 ± 51, aortic cross-clamping 54 ± 20 vs 57 ± 17, reperfusion 39 ± 21 vs 39 ± 14. The number of bypass grafts was also similar with use of the LIMA [GA1] (CABG-MAZE vs Sole-CABG) 0.9 ± 0.4 vs 0.9 ± 0.3 and did not differ significantly with use of venous grafts 1.9 ± 0.8 vs 1.2 ± 0.7. SR occurred (%) in the CABG-MAZE vs Sole-CABG group intraoperatively in 74 vs 98, decreased in parallel on postoperative day (POD) 1 and 3 to 54 vs 69 and 35 vs 58, and escalated again in parallel until 6 months and 1 year postoperatively to 51 vs 91 and 55 vs 87. AF-subgroups (paroxysmal, persistent, chronic) had converted to SR 1 year postoperatively in 70, 45 and 27%, respectively. Cumulative survival (%) for CABG-MAZE vs Sole-CABG was at POD 30 99 in both, at 6 months* 92 vs 99, and 1 year* 86 vs 98. Conclusions: Over half the patients with the combined CABG-MAZE operation had developed SR after 1 year. The reinstatement of SR in patients suffering from CAD and AF paralleled the rate of SR recovery in patients with preoperative SR and sole CABG procedure, 87% of whom showed SR 1 year after sole CABG. * significance p < 0.05
- 1 January 2014
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 62 (S 01) , OP132
Branched and fenestrated stent grafts - a reasonable option for thoraco-abdominal aortic aneurysm repair
Objectives: To evaluate the feasibility of totally endovascular repair for patients unfit for open thoraco-abdominal aortic aneurysm (TAAA) repair. Methods: In 31 patients, mean age 71 (45-85) years, 68% male (n = 21), TAAA of Crawford extent I-II in 39% (n = 12) and III-V in 61% (n = 19) were repaired. The procedures were part of a staged aortic repair with previous or secondary open or endovascular repair in 74% (n = 23). All procedures were performed under general anesthesia in a hybrid OR. Customized branched and/or fenestrated stent grafts were implanted: 16 Zenith and 15 E-vita E-xtra. A total of 112 celiac (CA), superior mesenteric (SMA) and renal arteries (RA) were connected to the stent grafts by 80 branches (72%) and 32 fenestrations (28%) with covered Advanta or Fluency stents reinforced by self-expandable bare stents for bridging to the target vessels. All fenestrations were stented with covered Advanta stents. Results: All stent grafts were implanted successfully and all target vessels were connected except 1 RA due to a kink at the origin, and 1 CA due to subtotal occlusion. In both cases the side branch socket at the stent graft was occluded with a plug, and 1 iliaco-renal bypass was performed. The occluded celiac artery showed excellent collaterals from the SMA. Mean procedure time was 430 (190-720) min and fluoroscopy time 103 min (52--246). In all patients discharge CT scans showed successful exclusion of the TAAA without Type I or Type III endoleak: in 25 patients (80%) primary and in 6 (20%) secondary exclusion (spontaneous closure in 2, secondary interventions in 4). Mortality at 30 days was 6.5% (1 due to pneumonia and 1 due to cerebral bleeding); incidence of spinal cord ischemia was 6.5% (n = 2) with 1 permanent paraplegia (3.2%). Conclusion: Endovascular repair with branched and fenestrated stent grafts proved a reasonable option for TAAA repair in a high-risk and advanced age cohort with low mortality and low incidence of paraplegia. This therapy is meanwhile available for urgent cases, since production time for the newer customized device has been reduced to 2-3 weeks. The procedures are time-consuming and technically demanding and the amount of radiation exposure is a concern. The bridging stent graft issue remains unsolved. In particular there is a risk of loose renal arteries with contemporary stiff stents. Thus further improvement of stent-graft technology, endovascular equipment and intraoperative imaging technology is required.
- 1 January 2014
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 62 (S 01) , OP132
Branched and fenestrated stent grafts - a reasonable option for thoraco-abdominal aortic aneurysm repair
Objectives: To evaluate the feasibility of totally endovascular repair for patients unfit for open thoraco-abdominal aortic aneurysm (TAAA) repair. Methods: In 31 patients, mean age 71 (45-85) years, 68% male (n = 21), TAAA of Crawford extent I-II in 39% (n = 12) and III-V in 61% (n = 19) were repaired. The procedures were part of a staged aortic repair with previous or secondary open or endovascular repair in 74% (n = 23). All procedures were performed under general anesthesia in a hybrid OR. Customized branched and/or fenestrated stent grafts were implanted: 16 Zenith and 15 E-vita E-xtra. A total of 112 celiac (CA), superior mesenteric (SMA) and renal arteries (RA) were connected to the stent grafts by 80 branches (72%) and 32 fenestrations (28%) with covered Advanta or Fluency stents reinforced by self-expandable bare stents for bridging to the target vessels. All fenestrations were stented with covered Advanta stents. Results: All stent grafts were implanted successfully and all target vessels were connected except 1 RA due to a kink at the origin, and 1 CA due to subtotal occlusion. In both cases the side branch socket at the stent graft was occluded with a plug, and 1 iliaco-renal bypass was performed. The occluded celiac artery showed excellent collaterals from the SMA. Mean procedure time was 430 (190-720) min and fluoroscopy time 103 min (52--246). In all patients discharge CT scans showed successful exclusion of the TAAA without Type I or Type III endoleak: in 25 patients (80%) primary and in 6 (20%) secondary exclusion (spontaneous closure in 2, secondary interventions in 4). Mortality at 30 days was 6.5% (1 due to pneumonia and 1 due to cerebral bleeding); incidence of spinal cord ischemia was 6.5% (n = 2) with 1 permanent paraplegia (3.2%). Conclusion: Endovascular repair with branched and fenestrated stent grafts proved a reasonable option for TAAA repair in a high-risk and advanced age cohort with low mortality and low incidence of paraplegia. This therapy is meanwhile available for urgent cases, since production time for the newer customized device has been reduced to 2-3 weeks. The procedures are time-consuming and technically demanding and the amount of radiation exposure is a concern. The bridging stent graft issue remains unsolved. In particular there is a risk of loose renal arteries with contemporary stiff stents. Thus further improvement of stent-graft technology, endovascular equipment and intraoperative imaging technology is required.
- 23 January 2013
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 61 (S 01)
Mortality reduction with IABP prior to CABG in emergency patients with shock
- 23 January 2013
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 61 (S 01)
Mortality reduction with IABP prior to CABG in emergency patients with shock
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 946
Sinus Rhythm after Heart Transplantation Denotes Favorable Course
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 946
Sinus Rhythm after Heart Transplantation Denotes Favorable Course
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 946
Absence of Sinus Rhythm or Its Loss as Risk Factors for Cardiac Graft Failure after Heart Transplantation
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 946
Absence of Sinus Rhythm or Its Loss as Risk Factors for Cardiac Graft Failure after Heart Transplantation
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 947
Preoperative Anti-Arrhythmic Medication in Heart Transplant Recipients Does not Negatively Influence Cardiac Function after Transplantation
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 947
Preoperative Anti-Arrhythmic Medication in Heart Transplant Recipients Does not Negatively Influence Cardiac Function after Transplantation
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 947
Amiodarone without Risk for Heart Transplant Recipients
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 947
Amiodarone without Risk for Heart Transplant Recipients
- 1 January 2009
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 56 (S 01) , P49
Pre-operative anti-arrhythmic medication of cardiac transplant recipients is without impact on sinus rhythm after heart transplantation
Objectives: Anti-arrhythmic medication regulates cardiac rhythm. We examined this preoperative influence on cardiac transplant recipients in the postoperative course after heart transplantation (HTx). Methods: We investigated 150 consecutive patients who underwent HTx in our institution between 1998 and 2000. Results: The preoperative cardiac rhythm showed sinus rhythm (n=75), sinus tachycardia (n=11), atrial fibrillation (n=50), pace maker stimulation (n=14). The substances administered preoperatively were digitalis (n=116), β-blocker (n=57), amiodarone (n=48), magnesium (n=13), sotalol (n=3), verapamil (n=2), propafenon (n=2). Postoperatively amiodarone (n=14), digoxine (n=12), and lidocaine (n=13) were given. Table: Number of patients (n) receiving preoperative anti-arrhythmic medication, their postoperative cardiac rhythm and number with good cardiac graft function (GOOD) or cardiac graft failure (FAILURE). Conclusions: Medication for anti-arrhythmic purposes in patients waiting for HTx is without influence on the occurrence or continuation of sinus rhythm after HTx. No preoperatively administered substance was associated with postoperative arrhythmia or with cardiac graft failure.
- 1 January 2009
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 56 (S 01) , P49
Pre-operative anti-arrhythmic medication of cardiac transplant recipients is without impact on sinus rhythm after heart transplantation
Objectives: Anti-arrhythmic medication regulates cardiac rhythm. We examined this preoperative influence on cardiac transplant recipients in the postoperative course after heart transplantation (HTx). Methods: We investigated 150 consecutive patients who underwent HTx in our institution between 1998 and 2000. Results: The preoperative cardiac rhythm showed sinus rhythm (n=75), sinus tachycardia (n=11), atrial fibrillation (n=50), pace maker stimulation (n=14). The substances administered preoperatively were digitalis (n=116), β-blocker (n=57), amiodarone (n=48), magnesium (n=13), sotalol (n=3), verapamil (n=2), propafenon (n=2). Postoperatively amiodarone (n=14), digoxine (n=12), and lidocaine (n=13) were given. Table: Number of patients (n) receiving preoperative anti-arrhythmic medication, their postoperative cardiac rhythm and number with good cardiac graft function (GOOD) or cardiac graft failure (FAILURE). Conclusions: Medication for anti-arrhythmic purposes in patients waiting for HTx is without influence on the occurrence or continuation of sinus rhythm after HTx. No preoperatively administered substance was associated with postoperative arrhythmia or with cardiac graft failure.
- 29 February 2008
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 27 (2) , S85-85
72: Sinus Rhythm after Heart Transplantation Denotes Favorable Course
- 29 February 2008
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 27 (2) , S85-85
72: Sinus Rhythm after Heart Transplantation Denotes Favorable Course